ISRCTN61582326进行中（未招募）Unknown
A 4-week clinical study to compare a new electrical toothbrush used with two different frequency settings to a manual control toothbrush in the reduction of gingivitis and plaque
Procter & Gamble (United States)0 个研究点目标入组 90 人开始时间: 2023年7月17日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Give written informed consent prior to study participation and be given a signed copy of their informed consent form
- •2. Be at least 18 years of age and mainly use a manual toothbrush;
- •3. Be in good general health as determined by the investigator/designee based on a review/update of their medical history;
- •4. Possess a minimum of 16 natural teeth with facial and lingual scorable surfaces;
- •5. Have localized or generalized gingivitis with a range of 10% to 70% bleeding sites (sites with a score of 1 or 2 on the GBI index) for Baseline exam);
- •6. Have a whole mouth mean MGI score between 1.75 and 2.5 for Baseline exam;
- •7. Have a whole mouth RMNPI score of greater than 0.5 for Baseline exam;
- •8. Agree not to participate in any other oral care study for the duration of this study;
- •9. Agree to not to have any elective dentistry, including dental prophylaxis, until study completion and to report any non-study dentistry received at any time during the course of this study;
- •10. Agree to refrain from using any non-study oral hygiene products for the study duration;
- •11. Agree to return for all their scheduled visits and to follow all study procedures;
- •12. Refrain from brushing their teeth or from performing any other oral hygiene procedure anytime within the 12 hours prior to Baseline Visit and agree to follow these same restrictions prior to all visits;
- •13. Refrain from medicated lozenges, breath mints, eating, drinking*, chewing gum and using tobacco (of any kind) for at least 4 hours prior to this visit and agree to follow these same restrictions prior to all visits. *(Allowed small sips of water up until 45 minutes prior to their appointments.)
排除标准
- •1. A condition requiring the need for antibiotic premedication prior to dental procedures;
- •2. Severe periodontal disease, including but not limited to, purulent exudates, generalized mobility, and/or severe recession;
- •3. Any carious lesions requiring restorative treatment;
- •4. Active treatment for the following conditions: periodontitis, cancer, or a seizure disorder;
- •5. Taking an antibiotic or using a chlorhexidine mouth rinse any time within the previous 2 weeks;
- •6. Having a dental prophylaxis any time within the previous 4 weeks;
- •7. Suffer from diabetes;
- •8. Taking anti-inflammatory or anti-coagulant medications any time within the previous 2 weeks;
- •9. Have any of the following: orthodontic appliances, removable partial dentures, peri/oral piercings, a pacemaker or other implanted device;
- •10. Oral/gum surgery within the previous two months;
- •11. A disease or condition that could possibly interfere with examination/procedures or with the subject’s safe completion of this study (including allergies to dye).
研究者
相似试验
已完成
不适用
A 4-week study to assess the efficacy of a new electric toothbrush to reduce dental plaque and gingival inflammatioEvidence of dental plaque and gingivitisOral HealthISRCTN13370721Procter & Gamble (United States)164
已完成
不适用
Effect of novel adjustment on plate`s retentioRetention of orthodontic plate.Fitting and adjustment of orthodontic deviceIRCT2014100819465N1Tabriz University of Medical Sciences45
进行中（未招募）
不适用
Ensayo clínico fase IV de comparación de la efectividad de dos pautas de administración de dinoprostona intravaginal en la inducción del parto en gestantes a término.Administración de dinoprostona intravaginal en la inducción del parto en gestantes a término.EUCTR2007-000704-32-ESCONSORCI SANITARI TERRASSA
尚未招募
4 期
This study compares the effectiveness and safety of the study product cylclosporin against Restasis in patients suffering from moderate to severe dry eye.CTRI/2019/03/018319ew India Bio Pharma Pvt Ltd
进行中（未招募）
不适用
Ensayo Clínico en fase IV para la comparación entre dos pautas de tratamiento (insulina humana vs análogos de insulina) respecto al riesgo de hipoglicemia y la variabilidad del control glicémico en pacientes con diabetes mellitus tipo 1: impacto sobre el HYPO score y el LI (lability index). - optimdiabDiabetes mellitus tipo 1. Variabilidad del control glicémico y riesgo de hipoglicemia con una pauta de insulina basada en analogos respecto a una con insulina humana.EUCTR2006-005817-36-ESDr Manuel Pérez Maraver.Servicio de Endocrinologia. Hospital de Bellvitge